TXMD News and Press, TherapeuticsMD Inc.

2024-03-29 16:21:11 ET More on Therapeutics MD Financial information for Therapeutics MD Read the full article on Seeking Alpha For further details see: Therapeutics MD reports FY results

• Evaluation of strategic alternatives continues TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the full year ended December 31, 2023...

2023-11-14 17:29:17 ET More on Therapeutics MD Seeking Alpha’s Quant Rating on Therapeutics MD Financial information for Therapeutics MD For further details see: TherapeuticsMD exploring strategic alternatives for company

2023-11-14 16:42:42 ET More on Therapeutics MD Seeking Alpha’s Quant Rating on Therapeutics MD Financial information for Therapeutics MD For further details see: Therapeutics MD GAAP EPS of -$0.13

Focus remains on cost control to maximize the value of our royalty assets Company announces evaluation of strategic alternatives TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical ro...

INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...

TherapeuticsMD Inc. (TXMD) is expected to report for Q3 2023

2023-08-14 06:52:04 ET Therapeutics MD press release ( NASDAQ: TXMD ): Q2 GAAP EPS of -$0.24. License and service revenues from continuing operations, which are revenues related to license agreements, were $0.4 million for the quarter ended June 30, 2023, compared to $0.3 ...

TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the second quarter ended June 30, 2023. “The Company’s transformation into a royalty-...

2023-05-24 13:33:04 ET In its preliminary annual 2023 Russell indexes reconstitution, a total of 164 companies will be added and 319 deleted from the Russell microcap index. Following notable healthcare companies will be added and deleted from Russell microcap index: Notable additio...